Biotech

All Articles

ArsenalBio elevates $325M, pivots off of previous lead property

.Toolbox Biosciences is carrying on up. The cell therapy provider has added $325 million in ammuniti...

Lilly- backed weight-loss biotech reports IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually fi...

Aelis' cannabis usage medication fails period 2b, steering Indivior to rethink $100M choice

.Aelis Farma's hopes of securing an easy, favorable selection on a $100 thousand option payment have...

ProKidney standstills phase 3 trial certainly not needed to have for tissue treatment permission

.ProKidney has ceased among a set of phase 3 trials for its own cell therapy for kidney illness afte...

Vaxcyte climbs on 'remarkable' 31-valent PCV gain against Pfizer

.Vaxcyte unveiled what professionals named "spectacular" phase 1/2 records for its own 31-valent pne...

Recursion's brain disease test shows little evidence of effectiveness

.Recursion has actually discovered by means of a very early test of its own tech-enabled method to m...

Acepodia, Pfizer click together for chemistry-based cell treatment

.Phone it a scenario of excellent chemistry: Acepodia, a biotech based upon Nobel Champion science, ...

Praxis epilepsy medication lowers confiscations in period 2 hearing

.Praxis Accuracy Medicines has actually scored an additional midphase win in epilepsy this year, alo...

Three directors surrender as Dyne messages blended data for DMD candidate

.After leaving a medical grip many years back, Dyne Rehab has revealed brand new period 1/2 data for...

Arrowhead fires off phase 3 records in rare metabolic ailment ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its give in advance of a potential face-off along with Ionis...